Journal Article10.1111/J.1365-2133.1989.TB01399.X
Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.
302
TL;DR: It is suggested that the use of oral erythromycin and/or topical clindamycin encourages the development of resistant propionibacteria and that the emergence of resistant strains is associated with therapeutic failure in erystromycin‐treated patients.
read more
Abstract: Erythromycin resistant (EmR) propionibacteria were isolated from the skin surface of 51% of patients treated with oral erythromycin and 42% of patients treated with topical clindamycin compared with 3% of untreated control subjects (P less than 0.001). Amongst the topical clindamycin-treated patients, there was a higher incidence of EmR propionibacterial carriage in those patients who had previously been treated with oral erythromycin (64%) than in patients with no known previous exposure to erythromycin (20%; 0.01 greater than P greater than 0.001). Patients responding to oral erythromycin treatment carried EmR propionibacteria less frequently (24%) than patients who were not responding or who had relapsed (70%; P less than 0.001). These observations suggest that the use of oral erythromycin and/or topical clindamycin encourages the development of resistant propionibacteria and that the emergence of resistant strains is associated with therapeutic failure in erythromycin-treated patients. In total 63 resistant isolates were obtained from 52 subjects. There were 42 strains of Propionibacterium acnes, 16 strains of Propionibacterium granulosum and five strains of Propionibacterium avidum. The majority of isolates were inducibly or constitutively resistant to macrolide (e.g. erythromycin), lincosamide (e.g. clindamycin) and streptogramin B type antibiotics. Therefore, the isolates are phenotypically indistinguishable from the majority of EmR bacteria in which resistance is due to methylation of 23S ribosomal RNA.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
acne vulgaris: A randomized, double-blind placebo-controlled acne vulgaris: A randomized, double-blind placebo-controlled acne vulgaris: A randomized, double-blind placebo-controlled acne vulgaris: A randomized, double-blind placebo-controlled acne vulgaris: A randomized, double-blind placebo-controlled study
Shahla Enshaieh,Abolfazl Jooya,Amir Hossein Siadat,Fariba Iraji +3 more
- 01 Jan 2007
TL;DR: Topical 5% tea tree oil is an effective treatment for mild to moderate acne vulgaris and side-effects with both groups were relatively similar and tolerable.
4
Arterial embolization caused by injection of hyaluronic acid (Restylane): reply from authors
S. Schanz,G. Fierlbech +1 more
TL;DR: A biopsy performed on a 40-year-old man reported the slow progressive appearance of pruritic erythematous lesions on the trunk, buttock, abdomen, axilla, genital area and forearm, and the most striking histological feature was a lymphocytic infiltrate involving eccrine glands and coils along with a characteristic epithelial hyperplasia.
3
Determination of Antimicrobial Susceptibility Patterns between Different Strains of Propionibacterium Acnes
W. N. Yusufu,H. O. Suleiman,V. Y. Akwa,D. L. David,A. Taiga +4 more
- 19 Jun 2019
TL;DR: This study supports the theory that most P. acnes isolates in deep tissues exhibit higher rate of antibiotic resistance and might be named the etiological agent of foreign-body infections like infections of indwelling medical devices.
Propionibacteria and Disease
Andrew McDowell,István Nagy +1 more
- 01 Jan 2015
TL;DR: This chapter provides an overview of the genus Propionibacterium, and describes the role played by the ‘cutaneous’ propionibacteria, especially P. acnes, in human disease, and covers virulence factors, mechanisms of antibiotic resistance, insights from whole-genome sequencing and immune responses.
3
References
Propionibacterium acnes resistance to antibiotics in acne patients
James J. Leyden,Kenneth J. McGinley,Stephen Cavalieri,Guy F. Webster,Otto H. Mills,Albert M. Kligman +5 more
TL;DR: The minimal inhibitory concentration of Propionibacterium acnes in seventy-five acne patients receiving long-term antibiotic therapy demonstrated the emergence of resistant strains.
236
Laboratory Induction and Clinical Occurrences of Combined Clindamycin and Erythromycin Resistance in Corynebacterium acnes
TL;DR: Corynebacterium acnes strains cross-resistant to clindamycin and erythromycin were observed following long-term selection or mutagenic treatment in the laboratory and it is suggested that this resistance may result from an alteration of the 50S ribosomal subunit.
100
Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment.
TL;DR: For most patients with recalcitrant acne a non‐microbiological explanation must be sought for the lack of therapeutic success, and the mean sebum excretion rate of the non‐responding patients was significantly higher than that of matched untreated acne patients.
45